COMPARATIVE-STUDY OF INVITRO INHIBITION OF ACTIVATION OF THE CLASSICAL AND ALTERNATIVE PATHWAYS OF HUMAN-COMPLEMENT BY THE MAGNESIUM AND SODIUM-SALTS OF THE ANTIINFLAMMATORY PEPTIDE N-ACETYL-ASPARTYL-GLUTAMIC ACID (NAAGA)

被引:7
作者
FEUILLARD, J [1 ]
MAILLET, F [1 ]
GOLDSCHMIDT, P [1 ]
WEISS, L [1 ]
KAZATCHKINE, MD [1 ]
机构
[1] HOP BROUSSAIS,SEROL INFECT & VIROL LAB,F-75674 PARIS 14,FRANCE
来源
AGENTS AND ACTIONS | 1991年 / 32卷 / 3-4期
关键词
D O I
10.1007/BF01980896
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The inhibitory activity of the sodium salt of the anti-inflammatory peptide N-acetyl-aspartyl-glutamic acid (NAAGA) on activation of the classical and alternative pathways of human complement was compared with that of the clinically used magnesium salt of NAAGA (NAAGA-Mg). Sodium salt of NAAGA (NAAGA-Na) inhibited both pathways of activation in a dose-dependent manner at concentration ranging from 1 to 10 mM by acting on formation and/or function of the C3 convertases as shown by the inhibitory capacity of the peptide on the release of the C3 cleavage fragment C3b and C3a. NAAGA-Na was as effective as NAAGA-Mg in inhibiting classical pathway activation at concentration above 10 mM. NAAGA-Na was more effective than NAAGA-Mg in inhibiting the alternative pathway since the sodium salt did not interfere with Mg-dependent formation of the alternative pathway C3 convertase.
引用
收藏
页码:343 / 346
页数:4
相关论文
共 13 条
[1]  
BLAMOUTIER J, 1988, ACTA THERAP, V14, P145
[2]   THE ABILITY OF SEPHADEX TO ACTIVATE HUMAN-COMPLEMENT IS SUPPRESSED IN SPECIFICALLY SUBSTITUTED FUNCTIONAL SEPHADEX DERIVATIVES [J].
CARRENO, MP ;
LABARRE, D ;
JOZEFOWICZ, M ;
KAZATCHKINE, MD .
MOLECULAR IMMUNOLOGY, 1988, 25 (02) :165-171
[3]   INVITRO INHIBITION OF THE CLASSICAL AND ALTERNATE PATHWAYS OF ACTIVATION OF HUMAN-COMPLEMENT BY N-ACETYL ASPARTYL GLUTAMIC-ACID (NAAGA) [J].
ETIEVANT, M ;
LELUC, B ;
DAVID, B .
AGENTS AND ACTIONS, 1988, 24 (1-2) :137-144
[4]   ACTIVATION-DEPENDENT ANTIGENIC CHANGES OF HUMAN C-3 [J].
GARRED, P ;
MOLLNES, TE ;
KAZATCHKINE, MD .
COMPLEMENT AND INFLAMMATION, 1989, 6 (03) :205-218
[5]   QUANTIFICATION IN ENZYME-LINKED IMMUNOSORBENT-ASSAY OF A C-3 NEOEPITOPE EXPRESSED ON ACTIVATED HUMAN-COMPLEMENT FACTOR-C3 [J].
GARRED, P ;
MOLLNES, TE ;
LEA, T .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1988, 27 (03) :329-335
[6]   ANAPHYLATOXIN-INDUCED HISTAMINE-RELEASE WITH HUMAN-LEUKOCYTES - STUDIES OF C3A LEUKOCYTE BINDING AND HISTAMINE-RELEASE [J].
GLOVSKY, MM ;
HUGLI, TE ;
ISHIZAKA, T ;
LICHTENSTEIN, LM ;
ERICKSON, BW .
JOURNAL OF CLINICAL INVESTIGATION, 1979, 64 (03) :804-811
[7]  
HAEFFNERCAVAILLON N, 1987, J IMMUNOL, V139, P794
[8]  
KAZATCHKINE MD, 1982, PROG ALLERGY, V30, P193
[9]  
Mayer M.M., 1967, EXPT IMMUNOCHEMISTRY, P133
[10]  
MILLS TAE, 1974, J IMMUNOL, V113, P348